Innovative Antibody Delivery System Promises End to Lengthy InfusionsTue 3rd Mar, 2026Researchers at the Massachusetts Institute of Technology (MIT) have developed a groundbreaking approach to administering therapeutic antibodies that could significantly transform treatment protocols for diseases including cancer. Traditionally, patients receiving antibody therapies endure prolonged intravenous infusions in hospital settings, a process that is both time-consuming and often uncomfortable. Overcoming Limitations in Antibody TreatmentAntibody-based medications have become a vital component in the treatment of several chronic and acute illnesses. This limitation has hindered the wider adoption of antibody therapies outside of specialist clinical settings. The new delivery system was shown to enable the injection of over 700 milligrams of antibodies in a single 2-milliliter syringe, a quantity sufficient for most therapeutic regimens.

Source: The Munich Eye March 03, 2026 22:49 UTC